Live from the NIH registry
Studies recruiting near Tulsa right now
Top 25 of 182 recruiting studies, sorted by proximity — each links to its official registry page
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Oklahoma Cancer Specialists and Research Institute-Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
Depression
Phase 2
Interventional 75 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laureate Institute for Brain Research, Inc.
A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
Wet Age Related Macular Degeneration
Phase 2
Interventional 66 participants sought
Tulsa Retina Consultants — Tulsa, Oklahoma (5.3 mi)
· Sponsor: NexThera Co., Ltd.
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0082) — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Amplification of Positivity for Alcohol Use
Alcohol Use Disorder, Anxiety
N/A
Interventional 100 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laureate Institute for Brain Research, Inc.
Dose-Dependent Effects of Low-Intensity Focused Ultrasound
Healthy Controls
N/A
Interventional 66 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laureate Institute for Brain Research, Inc.
Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression
Treatment-Resistant Depression
N/A
Interventional 140 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laureate Institute for Brain Research, Inc.
Mitigating PTSD-CUD After Sexual Assault
Posttraumatic Stress Disorder, Cannabis Use Disorder
Phase 1, Phase 2
Interventional 68 participants sought
Tulsa Forensic Nursing — Tulsa, Oklahoma (5.3 mi)
· Sponsor: University of Nevada, Las Vegas
Nectero EAST System Clinical Study
Abdominal Aortic Aneurysm
Phase 2, Phase 3
Interventional 400 participants sought
Oklahoma Heart Institute — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Nectero Medical, Inc.
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
AMI Cardiogenic Shock
N/A
Observational 350 participants sought
Saint Francis Hospital — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Abiomed Inc.
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
Normal and Diseased Tissue and Body Fluids Samples
N/A
Observational 100,000 participants sought
St. Jude Affiliate Clinic at Saint Francis Children's Hospital — Tulsa, Oklahoma (5.3 mi)
· Sponsor: St. Jude Children's Research Hospital
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Cancer, Metastatic, Cancer
N/A
Observational 50,000 participants sought
Massive Bio SYNERGY-AI site — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Massive Bio, Inc.
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Mitral Annular Calcification, Mitral Stenosis
N/A
Interventional 210 participants sought
Oklahoma Heart Institute Utica Office — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Mayra Guerrero
Decoding Emotional Dynamics in Bipolar Disorder
Bipolar Disorder I or II, Healthy (Controls)
N/A
Interventional 72 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laureate Institute for Brain Research, Inc.
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
Oklahoma Cancer Specialists and Research Institute, LLC — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Regeneron Pharmaceuticals
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Oklahoma Cancer Specialists and Research Institute (OCSRI) — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Paradigm Health
The Oklahoma Parent-Child Assistance Program
Substance Use Disorders, Pregnancy Related
N/A
Interventional 200 participants sought
Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: University of Oklahoma
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Oklahoma Cancer Specialists and Research Institute-Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Psoriatic Arthritis, Overweight or Obesity
Phase 4
Interventional 200 participants sought
Essential Medical Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Eli Lilly and Company
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Alopecia Areata
Phase 3
Interventional 1,330 participants sought
Vital Prospects Clinical Research Institute, PC — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Pfizer
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Tulsa Retina Consultants — Tulsa, Oklahoma (5.3 mi)
· Sponsor: EyeBiotech Ltd.
Pan Tumor Rollover Study
Cancer
Phase 2
Interventional 1,500 participants sought
Local Institution - 0246 — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Bristol-Myers Squibb
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Phase 4
Interventional 100 participants sought
Oklahoma Cancer Specialists and Research Institute, LLC — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Pfizer
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Axsome Therapeutics, Inc.
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Oklahoma Cancer Specialists and Research Institute-Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: NRG Oncology